首页> 外文期刊>Veterinary research >A multivalent vaccine candidate targeting enterotoxigenic Escherichia coli fimbriae for broadly protecting against porcine post-weaning diarrhea
【24h】

A multivalent vaccine candidate targeting enterotoxigenic Escherichia coli fimbriae for broadly protecting against porcine post-weaning diarrhea

机译:一种多价疫苗候选靶向肠毒素大肠杆菌的大肠杆菌,用于广泛保护猪断奶后腹泻

获取原文
           

摘要

Fimbriae-mediated initial adherence is the initial and critical step required for enterotoxigenic Escherichia coli (ETEC) infection. Therefore, vaccine candidates have been developed that target these fimbriae and induce specific anti-fimbriae antibodies to block initial ETEC attachment. While this vaccine effectively protects against ETEC-associated post-weaning diarrhea (PWD), developing a broadly effective vaccine against initial ETEC attachment remains a challenging problem, owing to the immunological heterogeneity among these antigens. Here, we applied multi-epitope fusion antigen (MEFA) technology to construct a FaeG–FedF–FanC–FasA–Fim41a MEFA using the adhesive subunits of predominant fimbriae K88 and F18 as the backbone, which also integrated epitopes from adhesive subunits of the rare fimbriae K99, 987P, and F41; we then generated a MEFA computational model and tested the immunogenicity of this MEFA protein in immunized mice. We next evaluated the potential of the fimbriae-targeted MEFA as a vaccine candidate to effectively prevent PWD using in vitro assessment of its anti-fimbriae, antibody-directed inhibition of bacterial adherence. Computational modeling showed that all relevant epitopes were exposed on the MEFA surface and mice subcutaneously immunized with the MEFA protein developed IgG antibodies to all five fimbriae. Moreover, anti-fimbriae antibodies induced by the MEFA protein significantly inhibited the adhesion of K88 , F18 , K99 , 987P , and F41 ETEC strains to piglet small intestinal IPEC-1 and IPEC-J2 cell lines. Taken together, these results indicate that FaeG–FedF–FanC–FasA–Fim41a MEFA protein induced specific anti-fimbriae neutralizing antibodies against the five targeted fimbriae. Critically, these results show the potential of fimbriae-targeted MEFA and indicate their promise as a broad, effective vaccine against PWD.
机译:FIMBRIAE介导的初始依从性是肠毒素大肠杆菌(ETEC)感染所需的初始和关键步骤。因此,已经开发了疫苗候选者,其靶向这些贫困,并诱导特定的抗FIMBRIAE抗体来阻止初始ETEC附着。虽然该疫苗有效地保护了与Etec相关的断奶后腹泻(PWD),但由于这些抗原之间的免疫异质性,仍然是一个充满挑战性问题的广泛有效的疫苗。在此,我们应用多表孔融合抗原(MEFA)技术,使用主要FIMBRIAE K88和F18的粘合剂亚基作为骨干构建FAEG-FEDF-FAC-FASA-FIM41A MEFA,其也是罕见的粘性亚基的集成表位FIMBRIAE K99,987P和F41;然后,我们产生了MEFA计算模型,并在免疫小鼠中测试了该MEFA蛋白的免疫原性。接下来,我们将Fimbria-靶向MEFA的潜力评估为疫苗候选者,以有效预防PWD,使用其抗FIMBRIAE的体外评估,抗体导向的细菌粘附性。计算建模表明,所有相关表位暴露在MeFA表面和用MeFA蛋白皮下免疫的小鼠发育IgG抗体对所有五种FIMBRIAE。此外,由MEFA蛋白诱导的抗FIMBRIAE抗体显着抑制K88,F18,K99,987P和F41 ETEC菌株对仔猪小肠IPEC-1和IPEC-J2细胞系的粘附性。总之,这些结果表明,FAEG-FEDF-FAND-FASA-FIM41A MEFA蛋白诱导特异性抗FIMBRIAE中和抗体对五个靶向的FIMBRIAE。批判性地,这些结果表明FIMBRIAE针对性MEFA的潜力,并将其承诺作为对PWD的广泛有效疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号